Muticentric evaluation of the MDR phenotype in leukemia

Leukemia

Volumn 11, Issue 7, 1997, Pages 1086-1094

  Marie, J P ^a   Huet, S ^b   Faussat, A M ^a   Perrot, J Y ^a   Chevillard, S ^c   Barbu, V ^d   Bayle, C ^e   Boutonnat, J ^f   Calvo, F ^g   Campos Guyotat, L ^h   Colosetti, P ⁱ   Cazin, J L ^j   De Cremoux, P ^k   Delvincourt, C ^l   Demur, C ^m   Drenou, B ⁿ   Fenneteau, O ^o   Feuillard, J ^p   Garnier Suillerot, A ^q   Genne, P ^r   Gorisse, M C ^l   Gosselin, P ^j   Jouault, H ^s   Lacave, R ^t   Le Calvez, G ^u   Leglise M C ^u   Leonce S ^v   Manfait, M ^w   Maynadie M ^x   Merle Beral H ^y   Merlin, J L ⁱ   Mousseau, M ^f   Morjani, H ^w   Picard, F ^z   Pinguet, F ^aa   Poncelet, P ^ab   Racadot, E ^ac   Raphael, M ^p   Richard, B ^ad   Rossi, J F ^ae   Schlegel, N ^o   Vielh, P ^k   Zhou, D C ^a   Robert, J ^b   more..

^a HÔTEL DIEU   (France)

^b INSTITUT BERGONIÉ   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HÔPITAL MICHALLON   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h HÔPITAL NORD   (France)

ⁱ CENTRE ALEXIS VAUTRIN   (France)

^j CENTRE OSCAR LAMBRET   (France)

^k INSTITUT CURIE   (France)

^l INSTITUT JEAN GODINOT   (France)

^m CHU PURPAN   (France)

ⁿ PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^o HÔPITAL ROBERT DEBRÉ   (France)

^p AVICENNE HOSPITAL   (France)

^q Laboratoire de Chimie Bioinorganique   (France)

^r UNIVERSITÉ DE BOURGOGNE   (France)

^s HENRI MONDOR HOSPITAL   (France)

^t HÔPITAL TENON   (France)

^u BREST UNIVERSITY HOSPITAL   (France)

^v INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^w UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^x DIJON UNIVERSITY HOSPITAL   (France)

^y PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^z Université Paris Descartes   (France)

^aa CENTRE VAL D AURELLE   (France)

^ab Biocytex   (France)

^ac Etablissement Transfus SFC   (France)

^ad NÎMES UNIVERSITY HOSPITAL   (France)

^ae HÔPITAL SAINT ELOI   (France)

more..

Author keywords

Flow cytometry; Immunocytochemistry; Leukemia; Multidrug resistance; P gp; Rhodamine efflux; RT PCR

Indexed keywords

GLYCOPROTEIN P; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; PARAFORMALDEHYDE; RHODAMINE; VERAPAMIL;

ARTICLE; CLINICAL ARTICLE; DRUG TRANSPORT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LABORATORY TEST; LEUKEMIA; LEUKEMIA CELL LINE; METHODOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; CELL CULTURE; CLINICAL TRIAL; IMMUNOPHENOTYPING; PHENOTYPE;

DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; P-GLYCOPROTEIN; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0031183426     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400656     Document Type: Article

References (24)

1. Marie JP. P-glycoprotein in adult hematological malignancies. Hematol/Oncol Clin N Am 1995; 9: 239-250.
2. Fisher G, Sikic B. Clinical studies with modulators of multidrug resistance. Hematol/Oncol Clin N Am 1995; 9: 363-382.
3. Beck W, Grogan T, Willman C, Cordon-Cardo C, Parham D, Kuttesch J, Andreeff M, Bates S, Berard C, Boyett J, Brophy N, Broxterman H, Chan H, Dalton W, Dietel M, Fojo A, Gascoyne R, Head D, Houghton P, Srivastava D, Lehnert M, Leith C, Paietta E, Pavelic Z, Rimsza L, Ronnson I, Sikic B, Twentyman P, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
4. Chevillard S, Vielh P, Valiride P, Marie J, Faussat A, Barbu V, Bayle C, Bénard J, Bonnal C, Boutonnat J, Calvo F, Charrier J, Clary A, Colosetti P, Danel-Moore L, De Crémoux P, Delvincourt C, Finat-Duclos F, Genne P, Kataki A, Kouyoumdjian J, Lacave R, Maugard C, Merlin J, Mousseau M, Pinguet F, Quillien V, Raphael M, Richard B, Verrelle P, Robert J. French multicentric evaluation of mdr1 gene expression in leukemia and solid tumors. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumors. Leukemia 1997 (in press).
5. Zhou DC, Ramond S, Viguié F, Faussat AM, Zittoun R, Marie JP. Progressive resistance to homoharringtonine in human myeloleukemia K562 cells: relationship to sequential emergence of MRP and MDR1 gene overexpression and MDR1 gene translation. Int J Cancer 1996; 65: 365-371.
6. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473-476.
7. Cazin J, Cazin B, Gosselin P, Doutrelan P, Fenaux P, Robert J, Boogaerts M, Van Acker K, Boniface B, Cappelaere P, Demaille A. Relationship between mdr1/PgP and functional activity in patients with chronic lymphocytic leukemia (CLL); correlation with clinical response. Proc Am Assoc Cancer Res 1996; 37: 308.
8. Huet S, Bennis S, Robert J, Gualde N. On the detection of classical multidrug resistant phenotype by flow cytometry. Anal Cell Pathol 1994; 6: 229.
9. Chevillard S, Pouillard P, Beldjord C, Asselain B, Beuzedoc P, Magdalenat H, Vielh P. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 1996; 77: 292-300.
10. Fenneteau O, Marie J, Lescoeur B, Vilmer E, Schlegel N. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia. Blood 1993; 82: 3787-3788.
11. Baker R, Chen Y, Richard B, Fredericks W, Cason E, Murawski M, Meegan R, Karakousis M, Center M, Slocum H, Rustum Y. Relation of multidrug resistance markers assessed by immunoblotting to clinical course of disease in adult sarcome. Proc Am Assoc Cancer Res 1993; 34: 232.
12. Mankhetkorn S, Dubru S, Hesschenbrouck J, Fiallo M, Garnier-Suillerot A. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of donorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mol Pharmacol 1996; 49: 532-539.
13. Millot J, Rasoanaivo T, Morjani H, Manfait M. Role of the aclacinomycin A-doxorubicin association in reversal of doxorubicin resistance in K562 tumor cells. Br J Cancer 1989; 69: 678-684.
14. Genne P, Duchamp O, Solary E, Pinard D, Belon J, Dimanche-Boitrel M, Chauffert B. Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM. Leukemia 1994; 8: 160-165.
15. Maynadié M, Lizard G, Solary E. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cell lines. Anticancer Res 1994; 14: 2605-2609.
16. Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari J, Atassi G. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cell lines displaying P-glycoprotein mediated multidrug resistance. Biochem Pharmacol 1992; 44: 1707-1715.
17. Carpentier Y, Gorisse M, Soize D. Evaluation of a method for detection of cells with reduced drug retention in solid tumors. Cytometry 1992; 13: 630-637.
18. Boutonnat J, Mousseau M, Bonnefoix T, Jacob M, Gressin P, Swiercz P, Sotto J. Flow cytometry analysis for identification of functional P-glycoprotein (Gp170) by daunorubicin (DNR) accumulation and for detection of glutathione S transferase π (GSTπ) in human non-Hodgkin lymphomas (HNHL). Anti Cancer Drugs 1994; 5: (Suppl. 1): 55.
19. Merlin J, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert J, Tsuruo T, Guerci O. Comparative evaluation of S9788, verapamil and cyclosporin 1 in K562 human leukemia cell lines and in P-glycoprotein expressing samples from patients with hematological malignancies. Blood 1994; 84: 262-269.
20. Lamy T, Drenou B, Grulois I, Fardel O, Jacquelinet C, Goasguen J, Dauriac C, Amiot L, Bernard M, Fauchet R, Leprise PY. Multidrug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. Leukemia 1995; 9: 1549-1555.
21. Zhou DC, Marie JP, Suberville AM, Zittoun R. Relevance of MDR-1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6: 879-885.
22. Ferrand V, Montero Julian F, Chauvet M, Hirn M, Bourdeaux M. Quantitative determination of the MDR-related P-glycoprotein, Pgp 170, by a rapid flow cytometric technique. Cytometry 1996; 23: 120-124.
23. Broxterman B, Sonneveld P, Feller N, Ossenkoppele G, Währer D, Eekman C, Schoester M, Lankelma J, Pinedo H, Löwenberg B, Schuurhuis G. Quality control of multidrug resistance assays in adult acute leukemia: correlations between assays for P-glycoprotein expression and activity. Blood 1996; 87: 4809-4816.
24. Schuurhuis G, Broxterman H, Ossenkoppele G, Baak J, Eekman C, Kuiper C, Feller N, van Heiningen H, Klumper E, Pieters R, Lankema J, Pinedo H. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin Cancer Res 1995; 1; 81-93.